2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR)
- PMID: 27594540
- DOI: 10.1016/j.atherosclerosis.2016.08.018
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR)
Keywords: apolipoprotein B; cholesterol; dyslipidaemias; high-density lipoproteins; lipoprotein remnants; low-density lipoproteins; total cardiovascular risk; treatment, adherence; treatment, drugs; treatment, lifestyle; triglycerides.
Comment in
-
Comments on the 2016 ESC/EAS Guidelines for the Management of Dyslipidemias.Rev Esp Cardiol (Engl Ed). 2017 Feb;70(2):72-77. doi: 10.1016/j.rec.2017.01.001. Rev Esp Cardiol (Engl Ed). 2017. PMID: 28131410 English, Spanish. No abstract available.
Similar articles
-
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).Atherosclerosis. 2011 Jul;217 Suppl 1:S1-44. doi: 10.1016/j.atherosclerosis.2011.06.012. Atherosclerosis. 2011. PMID: 21723445 Review. No abstract available.
-
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.Eur Heart J. 2016 Oct 14;37(39):2999-3058. doi: 10.1093/eurheartj/ehw272. Epub 2016 Aug 27. Eur Heart J. 2016. PMID: 27567407 No abstract available.
-
ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).Atherosclerosis. 2011 Jul;217(1):3-46. doi: 10.1016/j.atherosclerosis.2011.06.028. Atherosclerosis. 2011. PMID: 21882396 Review. No abstract available.
-
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).Eur Heart J. 2011 Jul;32(14):1769-818. doi: 10.1093/eurheartj/ehr158. Epub 2011 Jun 28. Eur Heart J. 2011. PMID: 21712404
-
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455. Eur Heart J. 2020. PMID: 31504418 No abstract available.
Cited by
-
Effects of a novel nutraceutical combination (BruMeChol™) in subjects with mild hypercholesterolemia: study protocol of a randomized, double-blind, controlled trial.Trials. 2020 Jul 6;21(1):616. doi: 10.1186/s13063-020-04551-4. Trials. 2020. PMID: 32631422 Free PMC article.
-
Therapeutics in Metabolic Diseases.Adv Exp Med Biol. 2023;1396:255-273. doi: 10.1007/978-981-19-5642-3_17. Adv Exp Med Biol. 2023. PMID: 36454472
-
Effects of Two Community-Based Exercise Programs on Adherence, Cardiometabolic Markers, and Body Composition in Older People with Cardiovascular Risk Factors: A Prospective Observational Cohort Study.J Pers Med. 2020 Oct 16;10(4):176. doi: 10.3390/jpm10040176. J Pers Med. 2020. PMID: 33081361 Free PMC article.
-
Prevalence of statin intolerance: a meta-analysis.Eur Heart J. 2022 Sep 7;43(34):3213-3223. doi: 10.1093/eurheartj/ehac015. Eur Heart J. 2022. PMID: 35169843 Free PMC article.
-
Attainment of Low-Density Lipoprotein Cholesterol Targets and Prescribing Pattern of Lipid-Lowering Medications among Patients with Familial Hypercholesterolemia Attending Specialist Clinics.J Atheroscler Thromb. 2023 Oct 1;30(10):1317-1326. doi: 10.5551/jat.63389. Epub 2022 Dec 23. J Atheroscler Thromb. 2023. PMID: 36567112 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical